Prokidney (PROK) Other financing activities (2021)

Prokidney (PROK) reported Other financing activities of $359666.0 for Q4 2021, little changed quarter-over-quarter from $359666.0 in Q3 2021.

Prokidney (PROK) Other financing activities (2021) Analysis & Trends

Prokidney (PROK) has 1 years of Other financing activities data on file, last reported at $359666.0 in Q4 2021.

Other financing activities for Q4 2021 came in at $359666.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2022 was $719332.0 (changed N/A YoY), and the FY2021 annual result was $359666.0, changed N/A from the prior year.
Other financing activities was little changed at $359666.0 in Q4 2021 per PROK's latest filing, from $359666.0 in the prior quarter.
Over five years, Other financing activities peaked at $359666.0 in Q3 2021 and troughed at $117.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Prokidney	259.01 Mn	1.55 Bn	-

Download Data